Adiponectin and a schematic representation of adiponectin-induced signaling pathways
Adiponectin and a schematic representation of adiponectin-induced signaling pathways. The binding of adiponectin to its receptor leads to the recruitment of APPL1 and APPL2, thereby activating a number of downstream signaling pathways. Adiponectin effects are mostly mediated via the AMPK and PPARα pathways. Stimulation of AMPK results in activation of SIRT1, essential in adiponectin’s regulation of glucose and lipid homeostasis, as well as enhanced eNOS activity, through which adiponectin interacts with endothelial cells. Moreover, activation of AMPK suppresses PI3K, mTOR and IKK/NF-κB signaling, exerting a cytoprotective effect of adiponectin. Adiponectin binding to AdipoRs, independently of AMPK, stimulates ceramidase activity and enhances ceramide catabolism and the formation of its metabolite—S1P, which is involved in angiogenesis. Activation of IRS1/2 by adiponectin causes increased PI3K/Akt/mTOR signaling, controlling cell survival, growth and apoptosis. Adiponectin signaling also activates other downstream intracellular signaling cascades through PKA, JNK and p38MAPK. Via SOCS3, adiponectin inhibits STAT3 activation, which increases proliferation, survival and invasion of cancer cells and suppresses anti-tumor immunity. ACC, acetyl-CoA carboxylase; AdipoR, adiponectin receptor; Akt, protein kinase B; AMPK, 5′-AMP-activated protein kinase; APPL1, adaptor protein containing a pleckstrin homology domain 1 protein; APPL2, adaptor protein containing a pleckstrin homology domain 2 protein; eNOS, endothelial nitric oxide synthase; IKK, IκB kinase; IRS, insulin receptor substrates; JNK, -Jun N-terminal kinase; MAPK, mitogen activated protein kinase; mTOR, the mammalian target of rapamycin; NF-κB, nuclear factor-κB; PI3K, phosphatidylinositol 3-kinase; PPARα, peroxisome proliferator-activated receptor gamma; S1P, sphingosine-1-phosphate; SIRT1, sirtuin 1; SOCS3, suppressors of cytokine signaling 3; STAT3, activator of transcription 3. Black arrows indicate activation of target protein, whereas small perpendicular red lines at the ends of the red lines indicate inhibitory effects. The figure was created by mindthegraph.com (accessed on 6 March 2023)
Publication
Role of Leptin and Adiponectin in Carcinogenesis (2023) Agnes Bocian-Jastrzębska, et al. Cancers (Basel). 2023 Sep;15(17). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IRS1 | IRS1 | ncbigene_symbol | IRS1 | 3667 |
| Homo sapiens | Primates | IRS1/2 | IRS2 | ncbigene_symbol | IRS2 | 8660 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR1A | 5573 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR1B | 5575 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR2A | 5576 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR2B | 5577 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACA | 5566 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACB | 5567 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACG | 5568 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAB2 | 5565 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG1 | 5571 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG2 | 51422 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG3 | 53632 |
| Homo sapiens | Primates | SOCS3 | SOCS3 | ncbigene_symbol | SOCS3 | 9021 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | APPL1 | APPL1 | ncbigene_symbol | APPL1 | 26060 |
| Homo sapiens | Primates | APPL2 | APPL2 | ncbigene_symbol | APPL2 | 55198 |
| Homo sapiens | Primates | APPL2 | APPL2 | ncbigene_synonym | APLP2 | 334 |
| Homo sapiens | Primates | Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | eNOS | ENOS | ncbigene_synonym | NOS3 | 4846 |
| Homo sapiens | Primates | eNOS | ENOS | ncbigene_synonym | ENO4 | 387712 |
| Homo sapiens | Primates | SIRT1 | SIRT1 | ncbigene_symbol | SIRT1 | 23411 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | S1P | S1P | ncbigene_synonym | MBTPS1 | 8720 |
| Homo sapiens | Primates | JNK | JNK | ncbigene_synonym | MAPK8 | 5599 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK10 | 5602 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| CERAMIDE | ceramide | an N-acylsphing-4-enine | chebi:52639 | |
| S1P | S1P | (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate | chebi:37550 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|